Biomarker monitoring in sports doping control

Bioanalysis

Volumn 4, Issue 10, 2012, Pages 1245-1253

  Pottgiesser, Torben ^a   Schumacher, Yorck Olaf ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; BIOLOGICAL MARKER; ERYTHROPOIETIN; HUMAN GROWTH HORMONE; RECOMBINANT ERYTHROPOIETIN;

ANALYTIC METHOD; ATHLETE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BODY POSTURE; DOPING; DRUG ABUSE; ERYTHROPOIESIS; EXERCISE; HUMAN; PRACTICE GUIDELINE; REVIEW; SCORING SYSTEM; TRAINING; URINALYSIS;

ATHLETES; BIOLOGICAL MARKERS; DOPING IN SPORTS; ERYTHROPOIETIN; HEMATOLOGIC TESTS; HUMANS; INTERNATIONAL AGENCIES; MONITORING, PHYSIOLOGIC; PERFORMANCE-ENHANCING SUBSTANCES; SUBSTANCE ABUSE DETECTION;

EID: 84861906715     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.101     Document Type: Review

References (71)

1. Ashenden M, Varlet-Marie E, Lasne F, Audran M. The effects of microdose recombinant human erythropoietin regimens in athletes. Haematologica 91(8), 1143-1144 (2006
2. Breidbach A, Catlin DH, Green GA, Tregub I, Truong H, Gorzek J. Detection of recombinant human erythropoietin in urine by isoelectric focusing. Clin. Chem. 49(6 Pt 1), 901-907 (2003
3. Lasne F, De Ceaurriz J. Recombinant erythropoietin in urine. Nature 405(6787), 635 (2000
4. Pottgiesser T, Umhau M, Ahlgrim C, Ruthardt S, Roecker K, Schumacher YO. Hb mass measurement suitable to screen for illicit autologous blood transfusions. Med. Sci. Sports Exerc. 39(10), 1748-1756 (2007
5. Sottas P-E, Saudan C, Saugy M. Doping: a paradigm shift has taken place in testing. Nature 455(7210), 166 (2008
6. Sottas PE, Robinson N, Saugy M. The athlete's biological passport and indirect markers of blood doping. Handb. Exp. Pharmacol. (195), 305-326 (2010
7. Donike M, Bärwald K, Klostermann K, Schänzer W, Zimmermann J. Nachweis von exogenem testosteron. In: Sport: Leistung und Gesundheit. Heck H, Hollmann W, Liesen H, Rost R (Eds).Deutscher ärzte-Verlag Köln, Germany, 293-298 (1983
8. UCI Sporting safety and condition regulations. Union Cycliste Internationale Lausanne. Chapter XIII, 13.01.023 (1997
9. Morkeberg J, Saltin B, Belhage B, Damsgaard R. Blood profiles in elite cross-country skiers: a 6-year follow-up. Scand. J. Med. Sci. Sports 19(2), 198-205 (2009
10. FIS Medical Committee. Medical Guide 2000/2001. International Ski Federation 13-14 (2000
11. Videman T, Lereim I, Hemmingsson P et al. Changes in hemoglobin values in elite crosscountry skiers from 1987-1999. Scand. J. Med. Sci. Sports 10(2), 98-102 (2000
12. Cazzola M. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica 85(6), 561-563 (2000
13. Sharpe K, Hopkins W, Emslie KR et al. Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica 87(12), 1248-1257 (2002
14. Ashenden MJ, Sharpe K, Schoch C, Schumacher YO. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes. Haematologica 89(8), 1019-1020 (2004
15. Ashenden MJ, Gore CJ, Parisotto R, Sharpe K, Hopkins WG, Hahn AG. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88(9), 1053-1062 (2003
16. Felding P, Petersen PH, Hørder M. The stability of blood, plasma and serum constituents during simulated transport. Scand. J. Clin. Lab. Invest. 41(1), 35-40 (1981
17. Johansson PI, Ullum H, Jensen K, Secher NH. A retrospective cohort study of blood hemoglobin levels in blood donors and competitive rowers. Scand. J. Med. Sci. Sports 19(1), 92-95 (2009
18. Audran M, Gareau R, Matecki S et al. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med. Sci. Sports Exerc. 31(5), 639-645 (1999
19. Parisotto R, Wu M, Ashenden MJ et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86(2), 128-137 (2001
20. Parisotto R, Gore CJ, Emslie KR et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85(6), 564-572 (2000
21. Gore CJ, Parisotto R, Ashenden MJ et al. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88(3), 333-344 (2003
22. Pottgiesser T, Sottas P-E, Echteler T, Robinson N, Umhau M, Schumacher YO. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study. Transfusion 51(8), 1707-1715 (2011
23. Morkeberg J, Sharpe K, Belhage B et al. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers. Scand. J. Med. Sci. Sports 21(2), 235-243 (2011
24. Nelson M, Popp H, Sharpe K, Ashenden M. Proof of homologous blood transfusion through quantification of blood group antigens. Haematologica 88(11), 1284-1295 (2003
25. Voss SC, Thevis M, Schinkothe T, Schanzer W. Detection of homologous blood transfusion. Int. J. Sports Med. 28(8), 633-637 (2007
26. Malcovati L, Pascutto C, Cazzola M. Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 88(5), 570-581 (2003
27. Sharpe K, Ashenden MJ, Schumacher YO. A third generation approach to detect erythropoietin abuse in athletes. Haematologica 91(3), 356-363 (2006
28. Sottas PE, Robinson N, Giraud S et al. Statistical classification of abnormal blood profiles in athletes. International J. Biostat. 2, 1-21 (2006
29. Robinson N, Sottas PE, Mangin P, Saugy M. Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica 92(8), 1143-1144 (2007
30. Ahlgrim C, Pottgiesser T, Robinson N, Sottas PE, Ruecker G, Schumacher YO. Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport? Int. J. Lab. Hematol. 32(5), 506-511 (2010
31. Robinson N, Mangin P, Saugy M. Time and temperature dependant changes in red blood cell analytes used for testing recombinant erythropoietin abuse in sports. Clin. Lab. 50(5-6), 317-323 (2004
32. Voss SC, Flenker U, Majer B, Schänzer W. Stability tests for hematological parameters in antidoping analyses. Lab. Hematol. 14(3), 24-29 (2008
33. Imeri F, Herklotz R, Risch L et al. Stability of hematological analytes depends on the hematology analyser used: a stability study with Bayer Advia 120, Beckman Coulter LH 750 and Sysmex XE 2100. Clin. Chim. Acta. 397(1-2), 68-71 (2008
34. Lippi G, Banfi G, Maffulli N. Preanalytical variability: the dark side of the moon in blood doping screening. Eur. J. Appl. Physiol. 109(5), 1003-1005 (2010
35. Banfi G, Lombardi G, Colombini A, Lippi G. A world apart: Inaccuracies of laboratory methodologies in antidoping testing. Clin. Chim. Acta. 411(15-16), 1003-1008 (2010
36. Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M. Stability and robustness of blood variables in an antidoping context. Int. J. Lab. Hematol. 33(2), 146-153 (2011
37. Lombardi G, Lanteri P, Colombini A, Lippi G, Banfi G. Stability of haematological parameters and its relevance on the athlete's biological passport model. Sports Med. 41(12), 1033-1042 (2011
38. Voss SC, Alsayrafi M, Alsowaidi N et al. The influence of exercise and circadian rhythm of haemoglobin concentration associated changes in plasma volume on the biological passport. Br. J. Sports Med. 45(15), A7 (2011
39. Schumacher YO, Sahm D, Baumstark MW, Pottgiesser T. Reticulocytes in athletes: Longitudinal aspects and the influence of long- and short-term exercise. Drug Test Anal. 2(10), 469-474 (2010
40. Schumacher YO, Wenning M, Robinson N, Sottas P-E, Ruecker G, Pottgiesser T. Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes. Int. J. Sports Med. 31(4), 225-230 (2010
41. Schumacher YO, Pottgiesser T. The impact of acute gastroenteritis on haematological markers used for the athletes biological passport - report of 5 cases. Int. J. Sports Med. 32(2), 147-150 (2011
42. Ashenden M, Clarke A, Sharpe K, d' Onofrio G, Allbon G, Gore CJ. Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport. J. Clin. Pathol. 65(1), 8-13 (2012
43. Ashenden M, Gough CE, Garnham A, Gore CJ, Sharpe K. Current markers of the Athlete Blood Passport do not flag microdose EPO doping. Eur. J. Appl. Physiol. 111(9), 2307-2314 (2011
44. Zorzoli M, Rossi F. Implementation of the biological passport: the experience of the International Cycling Union. Drug Test Anal. 2(11-12), 542-547 (2010
45. Schmidt W, Prommer N. The optimised COrebreathing method: a new tool to determine total haemoglobin mass routinely. Eur. J. Appl. Physiol. 95(5-6), 486-495 (2005
46. Prommer N, Sottas PE, Schoch C, Schumacher YO, Schmidt W. Total hemoglobin mass-a new parameter to detect blood doping? Med. Sci. Sports Exerc. 40(12), 2112-2118 (2008
47. Pottgiesser T, Specker W, Umhau M, Roecker K, Schumacher YO. Post-transfusion stability of haemoglobin mass. Vox Sang. 96(2), 119-127 (2009
48. Pottgiesser T, Specker W, Umhau M, Dickhuth HH, Roecker K, Schumacher YO. Recovery of hemoglobin mass after blood donation. Transfusion 48(7), 1390-1397 (2008
49. Eastwood A, Hopkins WG, Bourdon PC, Withers RT, Gore CJ. Stability of hemoglobin mass over 100 days in active men. J. Appl. Physiol. 104(4), 982-985 (2008
50. Eastwood A, Sharpe K, Bourdon PC et al. Within subject variation in hemoglobin mass in elite athletes. Med. Sci. Sports Exerc. 44(4), 725-732 (2012
51. Garvican LA, Eastwood A, Martin DT, Ross ML, Gripper A, Gore CJ. Stability of hemoglobin mass during a 6-day UCI ProTour cycling race. Clin. J. Sport Med. 20(3), 200-204.
52. Schumacher YO, Pottgiesser T, Ahlgrim C, Ruthardt S, Dickhuth HH, Roecker K. Haemoglobin mass in cyclists during stage racing. Int. J. Sports Med. 29(5), 372-378 (2008
53. Pottgiesser T, Echteler T, Sottas P-E, Umhau M, Schumacher YO. Hemoglobin mass and biological passport for the detection of autologous blood doping. Med. Sci. Sports Exerc. doi:10.1249/MSS.0b013e31823bcfb6 (2011) (Epub ahead of print
54. Lundby C, Robach P. Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations? Eur. J. Appl. Physiol. 108(1), 197-200 (2010
55. Gough CE, Sharpe K, Ashenden MJ et al. Quality control technique to reduce the variability of longitudinal measurement of hemoglobin mass. Scand. J. Med. Sci. Sports 21(6), e365-371 (2011
56. Alexander AC, Garvican LA, Burge CM, Clark SA, Plowman JS, Gore CJ. Standardising analysis of carbon monoxide rebreathing for application in anti-doping. J. Sci. Med Sport 14(2), 100-105 (2011
57. Monfort N, Ventura R, Latorre A, Belalcazar V, López M, Segura J. Urinary di-(2- ethylhexyl)phthalate metabolites in athletes as screening measure for illicit blood doping: a comparison study with patients receiving blood transfusion. Transfusion 50(1), 145-149 (2010
58. Monfort N, Ventura R, Platen P et al. Plasticizers excreted in urine: indication of autologous blood transfusion in sports. Transfusion 52(3), 647-657 (2012
59. Solymos E, Guddat S, Geyer H, Thomas A, Thevis M, Schänzer W. Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. Drug Test Anal. 3(11-12), 892-895 (2011
60. Solymos E, Guddat S, Geyer H et al. Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing. Anal. Bioanal. Chem. 401(2), 517-528 (2011
61. Sottas P-E, Saugy M, Saudan C. Endogenous steroid profiling in the Athlete Biological Passport. Endocrinol. Metab. Clin. North Am. 39(1), 59-73, viii-ix (2010
62. Sottas P-E, Robinson N, Rabin O, Saugy M. The Athlete Biological Passport. Clin. Chem. 57(7), 969-976 (2011
63. Handelsman DJ. Indirect androgen doping by oestrogen blockade in sports. Br. J. Pharmacol. 154(3), 598-605 (2008
64. Holt RIG, Sönksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br. J. Pharmacol. 154(3), 542-556 (2008
65. Liu H, Bravata DM, Olkin I et al. Systematic review: the effects of growth hormone on athletic performance. Ann. Intern. Med. 148(10), 747-758 (2008
66. Meinhardt U, Nelson AE, Hansen JL et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann. Intern. Med. 152(9), 568-577 (2010
67. Müller A, Scholz M, Blankenstein O et al. Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clin. Chem. Lab. Med. 49(7), 1135-1142 (2011
68. Powrie JK, Bassett EE, Rosen T et al. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 17(3), 220-226 (2007
69. Teale P, Barton C, Driver PM, Kay RG. Biomarkers: unrealized potential in sports doping analysis. Bioanalysis 1(6), 1103-1118 (2009
70. Noble WS. What is a support vector machine? Nat. Biotechnol. 24(12), 1565-1567 (2006
71. Schumacher YO, Pottgiesser T. Performance profiling: a role for sport science in the fight against doping? Int. J. Sports Physiol. Perform. 4(1), 129-133 (2009